Here's a growing list of the approved hormone therapies, immunotherapies and targeted therapies for treating cancer. Click on any of the drugs for more info on dosing, side effects and drug ...

Kamath and colleagues from Northwestern University’s Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center analyzed nonprofit cancer organizations with more than $5 million in ...

While new cancer diagnoses have decreased overall since the 1990s, increases in obesity-related cancers are likely slowing this progress, according to the CDC. About two thirds of U.S. adults and ...

For our sixth annual Cancer Health 25, we salute patient advocates for their unwavering efforts to support the cancer community. To be clear, our Cancer Health 25 is not a “best of” list or a “most ...

The Biden Initiative had begun to make progress toward those goals before it closed its doors for good. It created the Oncology Clinical Trial Information Commons, a collaboration among nine ...

Family Reach was started 25 years ago by two New Jersey families; each had lost a child to cancer. The families organized a golf tournament to raise money for families under financial duress from a ...

Breast cancer incidence among postmenopausal women at high risk for developing the disease continued to be significantly reduced 5.9 years after stopping five years of the aromatase inhibitor ...

Now, new guidelines developed by the Multinational Association of Supportive Care in Cancer (MASCC) and the International Society of Oral Oncology (ISOO) and published in the journal Supportive Care ...

Moderna and BioNTech are currently conducting clinical trials of therapies that use mRNA technology to treat cancer. The preliminary results are promising. One BioNTech cancer vaccine shrank tumors in ...

Strategic Philanthropy in Action By joining forces, we are paving the path to cures, by identifying the biggest opportunities where we can truly stimulate innovation and make significant advances in ...

In 1957, E. Donnall Thomas, MD, who would later become Fred Hutch’s first medical oncology director, published a landmark study in the New England Journal of Medicine about six patients with end-stage ...

Griffin, 55, has a net worth of about $36.5 billion and in 2023 was named one of the United States’ Most Generous Givers by Forbes. Last year, after Griffin donated $300 million to Harvard, the ...